Mometasone Furoate Monohydrate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

74 API Suppliers, 34 USDMF, 29 CEP/COS, 9 JDMF, 8 EU WC, 7 KDMF, 28 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

310 FDF Dossiers, 40 FDA Orange Book, 131 Europe, 21 Canada, 59 Australia, 29 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%, CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - 0.05MG/INH, AEROSOL, METERED;INHALATION - 0.10MG/INH, AEROSOL, METERED;INHALATION - 0.20MG/INH, SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, POWDER;INHALATION - 0.11MG/INH, POWDER;INHALATION - 0.22MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH, AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 4 DKSH, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 3 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 10 Kerry, 1 Kima Chemical, 6 Microlex e.U, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Pluviaendo, 1 Prachin Chemical, 9 Roquette, 6 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders, 21 Solubilizers, 17 Thickeners and Stabilizers, 17 Direct Compression, 11 Parenteral, 10 Coating Systems & Additives, 10 Co-Processed Excipients, 10 Topical, 9 Film Formers & Plasticizers, 7 Granulation, 6 Disintegrants & Superdisintegrants, 5 Rheology Modifiers, 5 Emulsifying Agents, 5 Controlled & Modified Release, 3 Lubricants & Glidants, 3 Taste Masking, 2 Chewable & Orodispersible Aids, 2 Surfactant & Foaming Agents, 2 Coloring Agents, 1 API Stability Enhancers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 49 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 110 Finished Drug Prices, 14 Annual Reports

MARKET PLACE

14 APIs, 4 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 US Patents, 1 US Exclusivities, 17 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls

Filters

Mometasone Furoate Monohydrate

Filters

FILTER :

filter Company Reset all filters

14 All

01 14Kerry

filter Capability Reset all filters

filter Country Reset all filters

01

Kerry

SHEFFCOAT™ CG

Pharma, Lab & Chemical Expo

Not Confirmed

Not Confirmed

Looking for Pharmaceutical Excipients offered by Kerry? Find Anhydrous Lactose,Glyceryl Monostearate,Microcrystalline Cellulose based excipient solutions to address drug delivery challenges on PharmaCompass.

Mometasone Furoate Monohydrate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

74 API Suppliers

34 USDMF

29 CEP/COS

9 JDMF

8 EU WC

7 KDMF

28 NDC API

42 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

50 Drugs in Development

INTERMEDIATES

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

310 FDF Dossiers

40 FDA Orange Book

131 Europe

21 Canada

59 Australia

29 South Africa

30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 0.1%

CREAM;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

AEROSOL, METERED;INHALATION - 0.05MG/INH

AEROSOL, METERED;INHALATION - 0.10MG/INH

AEROSOL, METERED;INHALATION - 0.20MG/INH

SPRAY, METERED;NASAL - 0.05MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

POWDER;INHALATION - 0.11MG/INH

POWDER;INHALATION - 0.22MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.05MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.1MG/INH

AEROSOL, METERED;INHALATION - 0.005MG/INH;0.2MG/INH

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

4 DKSH

6 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

6 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 BASF

3 DFE Pharma

2 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

10 Kerry

1 Kima Chemical

6 Microlex e.U

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

1 Pluviaendo

1 Prachin Chemical

9 Roquette

6 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Sigachi Industries

1 The Dow Chemical Company

1 Valens Pharmachem

1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

21 Fillers, Diluents & Binders

21 Solubilizers

17 Thickeners and Stabilizers

17 Direct Compression

11 Parenteral

10 Coating Systems & Additives

10 Co-Processed Excipients

10 Topical

9 Film Formers & Plasticizers

7 Granulation

6 Disintegrants & Superdisintegrants

CREAM;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION;TOPICAL - 0.1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SPRAY, METERED;NASAL - 0.05MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons